The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis
Open accessAbstract
Overexpression of transferrin receptor 1 (TFRC1), a major mediator of iron uptake in mammalian cells, is a common feature of human malignancies. Therapeutic strategies designed to interfere with tumor iron metabolism have targeted TFRC1. The c-Myc oncogenic transcription factor stimulates proliferation and growth by activating thousands of target genes. Here we demonstrate that TFRC1 is a critical downstream target of c-Myc. Using in vitro and in vivo models of B-cell lymphoma, we show that TFRC1 expression is activated by c-Myc. Chromatin immunoprecipitation experiments reveal that c-Myc directly binds a conserved region of TFRC1. In light of these findings, we sought to determine whether TFRC1 is required for c-Myc-mediated cellular proliferation and cell size control. TFRC1 inhibition decreases cellular proliferation and results in G1 arrest without affecting cell size. Consistent with these findings, expression profiling reveals that TFRC1 depletion alters expression of genes that regulate the cell cycle. Furthermore, enforced TFRC1 expression confers a growth advantage to cells and significantly enhances the rate of c-Myc-mediated tumor formation in vivo. These findings provide a molecular basis for increased TFRC1 expression in human tumors, illuminate the role of TFRC1 in the c-Myc target gene network, and support strategies that target TFRC1 for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationIdentifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Self-citationA Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis
Vindeløv, L. L., Christensen, I. J., & Nissen, N. I. (1983) · Cytometry · doi:10.1002/cyto.990030503 · Cited by 1,639
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Genomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Ellwood-Yen, K., Graeber, T. G., Wongvipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V., & Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00197-1 · Cited by 816
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis
Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O'Donnell, K. A., Kim, J.-W., Yustein, J. T., Lee, L. A., & Dang, C. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6225-6234.2005 · Cited by 614
Self-citationStructure of the human transferrin receptor-transferrin complex
Cheng, Y., Zak, O., Aisen, P., Harrison, S. C., & Walz, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00130-8 · Cited by 571 · cited 1×
“The transferrin receptor (TFRC1/TFR/p90/CD71) is a key cell surface molecule that regulates uptake of iron-bound transferrin by receptor-mediated endocytosis (8).”
BackgroundLinke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 531
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., & Ren, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332764100 · Cited by 524
Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r69 · Cited by 482
Self-citationThe myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
Eilers, M., Picard, D., Yamamoto, K. R., & Bishop, J. M. (1989) · Nature · doi:10.1038/340066a0 · Cited by 458
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., & Lee, W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1697 · Cited by 447
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 443
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network
Orian, A., van Steensel, B., Delrow, J., Bussemaker, H. J., Li, L., Sawado, T., Williams, E., Loo, L. W. M., Cowley, S. M., Yost, C., et al. (2003) · Genes & Development · doi:10.1101/gad.1066903 · Cited by 387
c-Myc enhances protein synthesis and cell size during B lymphocyte development
Iritani, B. M., & Eisenman, R. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13180 · Cited by 364
Modulation of cell surface iron transferrin receptors by cellular density and state of activation
Larrick, J. W., & Cresswell, P. (1979) · Journal of Supramolecular Structure · doi:10.1002/jss.400110415 · Cited by 357
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC
Wu, K.-J., Polack, A., & Dalla-Favera, R. (1999) · Science · doi:10.1126/science.283.5402.676 · Cited by 326
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation
Cole, M. D., & McMahon, S. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202748 · Cited by 314
The transcriptional program of a human B cell line in response to Myc
Schuhmacher, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.2.397 · Cited by 310
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285
c-Myc target gene specificity is determined by a post-DNAbinding mechanism
Boyd, K. E., Wells, J., Gutman, J., Bartley, S. M., & Farnham, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13887 · Cited by 276
Iron chelators as therapeutic agents for the treatment of cancer
Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00218-9 · Cited by 227
A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns
O'Connell, B. C., Cheung, A. F., Simkevich, C. P., Tam, W., Ren, X., Mateyak, M. K., & Sedivy, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210462200 · Cited by 227
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P. J., Brown, P. O., Botstein, D., & Levy, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132253599 · Cited by 226
Grandori, C., Mac, J., Siëbelt, F., Ayer, D. E., & Eisenman, R. N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00808.x · Cited by 208
Cell cycle activation by c-myc in a Burkitt lymphoma model cell line
Pajic, A., Spitkovsky, D., Christoph, B., Kempkes, B., Schuhmacher, M., Staege, M. S., Brielmeier, M., Ellwart, J., Kohlhuber, F., Bornkamm, G. W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<787::aid-ijc4>3.0.co;2-6 · Cited by 207
The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation
Wonsey, D. R., Zeller, K. I., & Dang, C. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102523299 · Cited by 205
Self-citationNikiforov, M. A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J. M., & Cole, M. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5793-5800.2002 · Cited by 201
Effects of c-myc Expression on Cell Cycle Progression
Hanson, K. D., Shichiri, M., Follansbee, M. R., & Sedivy, J. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5748-5755.1994 · Cited by 159
Antineuroblastoma activity of desferoxamine in human cell lines.
Blatt, J., & Stitely, S. (1987) · PubMed · Cited by 147
Chitambar, C. R., Massey, E. J., & Seligman, P. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111087 · Cited by 133
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformationPreprint
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 130
Characterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation
Zeller, K. I., Haggerty, T. J., Barrett, J. F., Guo, Q. M., Wonsey, D. R., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108506200 · Cited by 123
Self-citationNeoplastic Transformation by the Human Gene N-myc
Small, M. B., Hay, N., Schwab, M., & Bishop, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1638 · Cited by 117
Moura, I. C. (2004) · Blood · doi:10.1182/blood-2003-07-2440 · Cited by 114
Secombe, J., Pierce, S. B., & Eisenman, R. N. (2004) · Cell · doi:10.1016/s0092-8674(04)00336-8 · Cited by 109
Haggerty, T. J., Zeller, K. I., Osthus, R. C., Wonsey, D. R., & Dang, C. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931346100 · Cited by 108
Self-citationDeferoxamine inhibition of human neuroblastoma viability and proliferation.
Becton, D. L., & Bryles, P. (1988) · PubMed · Cited by 103
Functional analysis of the N-terminal domain of the Myc oncoprotein
Oster, S. K., Mao, D. Y. L., Kennedy, J. L., & Penn, L. Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206228 · Cited by 87
The mechanism of 67Ga localization in malignant disease
Weiner, R. E. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00119-9 · Cited by 83
Effects of anti‐transferrin receptor antibodies on growth of normal and malignant myeloid cells
Taetle, R., Honeysett, J. M., & Trowbridge, I. S. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910320314 · Cited by 81
Fan, L., Iyer, J., Zhu, S., Frick, K. K., Wada, R. K., Eskenazi, A. E., Berg, P. E., Ikegaki, N., Kennett, R. H., & Frantz, C. N. (2001) · PubMed · Cited by 64
Transferrin Receptor Expression and the Control of Cell Growth
Neckers, L. Μ., & Trepel, J. B. (1986) · Cancer Investigation · doi:10.3109/07357908609017524 · Cited by 64
Yu, D., Allman, D. A., Goldschmidt, M. H., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1797 · Cited by 63
Self-citationYu, D., & Thomas‐Tikhonenko, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205244 · Cited by 54
Self-citationRemondini, D., O’Connell, B. C., Intrator, N., Sedivy, J. M., Neretti, N., Castellani, G., & Cooper, L. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502081102 · Cited by 50
Therapeutic Potential of Iron Chelators in Cancer Therapy
Richardson, D. R. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0593-8_12 · Cited by 40 · cited 1×
“Desferrioxamine (DFX) is a potent iron chelator that has been shown to inhibit the growth of aggressive tumors, such as neuroblastoma and leukemia (3, 4, 46) and is currently used to treat iron-overload disorders (45).”
BackgroundYu, D., Dews, M., Park, A., Tobias, J. W., & Thomas‐Tikhonenko, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4197 · Cited by 34
Self-citationThe transferrin receptor: a key function in iron metabolism.
Kühn, L. C. (1989) · PubMed · Cited by 21
Characterization of the Murine Nramp1 Promoter
Bowen, H., Lapham, A. S., Phillips, E. S., Yeung, I., Alter-Koltunoff, M., Levi, B.-Z., Perry, V. H., Mann, D. A., & Barton, C. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304301200 · Cited by 13
c-Myc represses the murine Nrampl promoter
Bowen, H., Biggs, T. E., Baker, S. T., Phillips, E. S., Perry, V. H., Mann, D. A., & Barton, C. H. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300774 · Cited by 12
Cited by
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Self-citationWidespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationThe interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Self-citationMYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
Self-citation
Metadata
- Authors
- O'Donnell, K. A., Yu, D., Zeller, K. I., Kim, J.-W., Racke, F., Thomas-Tikhonenko, A., & Dang, C. V.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-03
- Volume
- 26
- Issue
- 6
- Pages
- 2373-2386
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2102612894
- Cited by
- 253
- References
- 62
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.